John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INDT
1601
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $1.21M | ﹤0.01% |
16,515
+10,515
| +175% | +$803K |
|
|
ABTX
1602
DELISTED
Allegiance Bancshares
ABTX
| $1.2M | ﹤0.01% |
26,942
-13,084
| -33% | -$573K |
|
1603
BayCom
BCML
$327M
| $1.2M | ﹤0.01% |
+55,253
| New | +$1.18M |
|
1604
Vishay Precision Group
VPG
$858M
| $1.2M | ﹤0.01% |
37,413
-3,314
| -8% | -$107K |
|
|
CCF
1605
DELISTED
Chase Corporation
CCF
| $1.2M | ﹤0.01% |
13,825
+4,014
| +41% | +$372K |
|
1606
Nature's Sunshine
NATR
$251M
| $1.2M | ﹤0.01% |
71,345
+13,593
| +24% | +$240K |
|
|
OCDX
1607
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $1.2M | ﹤0.01% |
64,312
-148,830
| -70% | -$2.68M |
|
1608
El Pollo Loco
LOCO
$479M
| $1.2M | ﹤0.01% |
+103,222
| New | +$1.33M |
|
1609
Arhaus
ARHS
$1.26B
| $1.2M | ﹤0.01% |
140,771
+56,361
| +67% | +$469K |
|
1610
Gladstone Capital
GLAD
$448M
| $1.2M | ﹤0.01% |
50,800
-19,910
| -28% | -$447K |
|
|
STXB
1611
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $1.2M | ﹤0.01% |
45,585
+29,184
| +178% | +$835K |
|
|
ICAD
1612
DELISTED
iCAD Inc
ICAD
| $1.2M | ﹤0.01% |
268,447
+50,670
| +23% | +$255K |
|
1613
AdvanSix
ASIX
$442M
| $1.19M | ﹤0.01% |
+23,361
| New | +$1.04M |
|
1614
Phibro Animal Health
PAHC
$1.45B
| $1.19M | ﹤0.01% |
59,856
+1,409
| +2% | +$28.5K |
|
1615
Ponce Financial Group
PDLB
$488M
| $1.19M | ﹤0.01% |
+115,036
| New | +$1.22M |
|
1616
Liberty Media Series A
FWONA
$24.1B
| $1.19M | ﹤0.01% |
19,663
-67,980
| -78% | -$3.68M |
|
1617
Herc Holdings
HRI
$5.24B
| $1.19M | ﹤0.01% |
7,103
-30,385
| -81% | -$4.8M |
|
1618
Taysha Gene Therapies
TSHA
$2.03B
| $1.19M | ﹤0.01% |
181,908
+112,679
| +163% | +$842K |
|
1619
Kelly Services Class A
KELYA
$588M
| $1.18M | ﹤0.01% |
54,591
+5,564
| +11% | +$108K |
|
1620
Cooper-Standard Automotive
CPS
$477M
| $1.18M | ﹤0.01% |
+134,533
| New | +$2.2M |
|
|
CBL
1621
CBL Properties
CBL
$1.73B
| $1.17M | ﹤0.01% |
35,590
+28,793
| +424% | +$831K |
|
1622
Amkor Technology
AMKR
$12.1B
| $1.17M | ﹤0.01% |
+53,792
| New | +$1.22M |
|
1623
Praxis Precision Medicines
PRAX
$10.2B
| $1.17M | ﹤0.01% |
7,618
-2,526
| -25% | -$519K |
|
1624
Independence Realty Trust
IRT
$3.96B
| $1.17M | ﹤0.01% |
44,076
-1,666,835
| -97% | -$40.9M |
|
1625
Digi International
DGII
$2.85B
| $1.16M | ﹤0.01% |
54,027
+31,879
| +144% | +$681K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.